Veterinary Rehabilitation Services Market
The global veterinary rehabilitation services market demand is worth US$ 792.5 Million in 2022 and is expected to achieve a market valuation of US$ 882 Million in 2023. It is expected to reach a market valuation of US$ 2.1 Billion by the end of the forecast period while showing of a CAGR of 9.06% by 2033.
The global veterinary rehabilitation services industry is witnessing an unprecedented increase in demand, driven by the growing emphasis on pet health and increasing pet ownership worldwide. As more pet owners recognize the importance of holistic care and post-operative rehabilitation for their beloved companions, the market for veterinary rehabilitation services is expanding at a remarkable pace.
Get a Recently Updated Market Report as a Sample Copy! https://www.futuremarketinsights.com/reports/sample/rep-gb-15946
In recent years, there has been a dramatic shift in pet owners’ attitudes toward health care for their furry friends. Increasing awareness about the benefits of veterinary rehabilitation, along with advances in medical technologies and treatment methods, has changed the landscape of pet care.
The primary goal of veterinary rehabilitation services is to restore and maintain optimal physical function, relieve pain, and improve the overall quality of life for animals. These services encompass a wide range of therapeutic techniques, including physical therapy, hydrotherapy, acupuncture, chiropractic care, and more. Through a multidisciplinary approach, veterinarians and rehabilitation specialists work together to develop personalized treatment plans tailored to each patient’s unique needs.
Key Takeaways:
- The Veterinary Rehabilitation Services Industry is valued at US$ 882 Million in 2023 and will reach an impressive value of US$ 2.1 billion while exhibiting a CAGR of 9.06% by 2033.
- Trends in pet humanization and increasing pet spending are fueling the growth of the veterinary rehab service market.
- By Animal type, the companion animal segment is expected to dominate the market with a 70% revenue share by 2033.
- By type of therapy, the therapeutic exercises segment is expected to generate the highest revenue during the forecast period.
- By Indication type, the Post surgery segment accounts for a market share of 31% by 2022 and is expected to lead the segment by the end of the forecast period.
- By End-use, Veterinary rehab centers dominated the market with a 45.8% segment share in 2022.
- APAC will exhibit the highest CAGR of 13% in the veterinary rehab service market in the coming years.
“The market expansion can be attributed to a paradigm shift towards workflows and process automation across a wide range of businesses and industrial verticals. Businesses around the world are eager to embrace effective and streamlined business processes that can be executed regardless of location, driving this industry forward.” commented a Future Market Insights analyst
Dive Deep into Data-driven Methodology for Insights: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-15946
Competitive Landscape:
Some of the key company profiles included in the global Veterinary Rehabilitation Services Industry report are-
- Back to Track Veterinary Rehabilitation Center, LLC
- Animal Acupuncture and Rehabilitation Center
- BARC
- Treasure Coast Animal Rehab & Fitness
- Animal Rehab Center of Michigan
- Blue Springs Animal Rehabilitation Center
- Essex Animal Hospital
- Triangle Veterinary Referral Hospital
- Butterwick Animal Rehab Clinic Ltd
- Animal Rehab and Conditioning Center
In April 2022, the FDA approved injections of Vatinoxan hydrochlorides and Medetomidine for dogs undergoing specific clinical tests and procedures and minor surgical procedures. Medetomidine is a synthetic drug used as a surgical anesthetic and an analgesic. Vatinoxan reduces the adverse cardiovascular effects of medetomidine by keeping the heart rate in the normal range, thus improving cardiovascular function and the safety profile of medetomidine while the dog is sedated. Zenalpha is intended to provide sedation and pain relief that lasts the duration of sedation in dogs for clinical examinations or procedures that require the dog to remain quiet, calm or still.
In January 2022, the US FDA granted approval to Elanco Animal Health’s Zorbium (buprenorphine transdermal solution). Because of this approval, veterinarians now have another alternative for managing postoperative pain in cats, because of this approval.
Act Now to Explore In-Depth Market Analysis: Get Exclusive Buy Now to Access! https://www.futuremarketinsights.com/checkout/15946
Key Segments Profiled in the Veterinary Rehabilitation Services Industry Survey:
By Animal Type:
- Companion Animals
- Wildlife Animals
- Production Animals
By Type of Therapy:
- Therapeutic Exercises
- Manual Therapy
- Hydrotherapy
- Hot & Cold Therapies
- Electrotherapies
- Acupuncture
- Shockwave Therapy
- Other Therapies
By Indication:
- After the Operation
- Traumatic Injuries
- Chronic and Chronic Illness
- Developmental Abnormalities
- Other Indications
In End Use:
- Veterinary Rehab Centers and Hospitals
- Rescue & Shelter Homes
- Rehab Sanctuary
- The others
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award recipient, and a member of the Greater New York Chamber of Commerce) offers deep insight into the driving factors fueling market demand. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With an extensive team of more than 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends in more than 110 countries.
Contact us:
Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
Q: +1-845-579-5705
For Sales Questions: [email protected]
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
